The thyroid, a vital endocrine organ in vertebrates, plays a key role in regulating metabolism and supporting growth. The ...

T cells and/or bispecific antibody (BsAb) has been established and become a promising treatment strategy for ...

Swedish biotech Cellcolabs believes stem cell therapies are approaching commercial scale — a landmark poised to transform ...

New findings about the effect of certain mutated cells on the entire blood-forming system and its environment could change ...

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

Preclinical research has demonstrated that CX-5461 exhibits strong inhibitory effects against MYC-overexpressing tumors, highlighting its potential as a next-generation targeted cancer ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials ...

Hepatocellular carcinoma remains a substantial global public health concern, disproportionately affecting low-income and middle-income countries, particularly in Africa.1 Its burden in Africa is ...

Allogene Therapeutics halts ALLO-647 trial in large B-cell lymphoma after a patient death raises safety concerns, impacting ...

Cod liver oil is high in several key omega-3 fatty acids, vitamin D, and vitamin A. It can improve cardiac health, lower lipid levels, and reduce overall inflammation.

Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Samuel So, MBBS, FACS, a globally recognized ...

CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 ...